Gyeonggi-do, South Korea

Hee Jeong Shin


Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Hee Jeong Shin: Innovator in Bacteriophage Research

Introduction

Hee Jeong Shin is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of bacteriophage research, holding a total of seven patents. His work focuses on innovative methods for preventing and treating diseases using bacteriophages.

Latest Patents

Among his latest patents are two notable inventions. The first is the bacteriophage Clo-PEP-2, which is capable of inhibiting the proliferation of certain pathogens. This Siphoviridae bacteriophage, identified by accession number KCTC 13185BP, has a genome expressed by sequence number 1. The invention details a method for preventing or treating diseases induced by this bacteriophage through a composition that includes Clo-PEP-2 as an active ingredient. The second patent involves the bacteriophage Pse-AEP-4, a Podoviridae bacteriophage isolated from nature. This bacteriophage, with accession number KCTC 13166BP, is designed to specifically kill pathogens and has a genome represented by SEQ ID NO: 1. The patent outlines a method for preventing or treating diseases induced by using a composition containing Pse-AEP-4 as an active ingredient.

Career Highlights

Hee Jeong Shin is currently associated with Intron Biotechnology, Inc., where he continues to advance his research in bacteriophage technology. His innovative work has positioned him as a key figure in the field, contributing to the development of new therapeutic approaches.

Collaborations

He has collaborated with notable colleagues, including Seong Jun Yoon and SAng Hyeon Kang, who have supported his research endeavors.

Conclusion

Hee Jeong Shin's contributions to bacteriophage research exemplify the potential of innovative solutions in combating diseases. His patents reflect a commitment to advancing medical science through the use of natural bacteriophages.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…